Coronary disease & ACSDiagnostic or prognostic study

Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment

HeartPublished

  • Diagnostic performance analysis of troponin assays
  • four acute tertiary care hospitals in London, UK
  • 2010–2017

Authors' conclusion

The diagnostic performance of an unadjusted troponin cut-off for AMI falls with worsening renal function. We propose consideration of eGFR specific cut-offs to support more effective triage and early management of suspected AMI in patients with renal impairment.

Study context

Population
Patients with troponin measurement at four acute tertiary care hospitals in London, UK, between 2010 and 2017patients included
Participants
221,175 patients
Comparison
Troponin for diagnosing acute myocardial infarction (AMI), stratified by estimated glomerular filtration rate (eGFR)

Performance

As reported in the abstract

Patient characteristics

Median age

65 years (IQR 49-79)

eGFR <60 mL/min/1.73 m 2

20.6%

Diagnosis of AMI

6.4%

Further findings

Relationship between eGFR and troponin in patients without AMI

Inverse log-linear relationship between eGFR and troponin

Diagnostic performance for AMI by eGFR

eGFR>90, C-statistic (best)
0.93
eGFR<15, C-statistic (worst)
0.81

False positive rate of high-sensitive troponin T at conventional cut-off of 14 ng/L, eGFR 15–60 mL/min/1.73 m 2

False positive rates
68-93%

eGFR-specific cut-offs restricting false positive rate to 15%

eGFR 45-60: cut-off
73 ng/L
eGFR 45-60: detection rate
73%
eGFR 30-45: cut-off
112 ng/L
eGFR 30-45: detection rate
70%
eGFR 15-30: cut-off
184 ng/L
eGFR 15-30: detection rate
68%

Original publication

Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment. Heart. Published 9 June 2026. doi:10.1136/heartjnl-2025-327658

Summarised from the published abstract; every number is checked against it